Surgemetry

The description states that Surgemetry is a case-centered perioperative governance and accountability layer. It connects:

• Case readiness dependencies and hard blockers
• OR flow, block use, turnover, and after-hours activity
• Anesthesia coverage and ASA-unit context
• Journey events, cancellations, PACU, discharge, and disruption attribution
• Directional expense, reimbursement, denial, payment, and collection signals
• Data-quality warnings, governance prompts, and an auditable local event trail

It does not replace systems of record like Epic or Oracle Health/Cerner. Instead, it provides a vendor-neutral reconciliation and governance layer above them.

The prototype uses Python, pandas, NumPy, Streamlit, Altair, Pydantic, pytest, and local CSV files. It includes synthetic datasets, deterministic calculations, and an optional bounded GPT-5.6 feature for executive draft generation.

Not evidenced:

• Whether any live hospital connectors exist
• Whether the system handles PHI or claims HIPAA compliance
• Whether the prototype has been tested in real-world settings

The author states that Surgemetry is a case-centered governance layer. It aims to unify fragmented data around surgical cases and turn it into actionable leadership intelligence.

The positioning evolved from an idea to a synthetic prototype, with claims of:

• Connecting dependencies across perioperative workflows
• Assigning accountable review and linking operational events to financial consequences
• Providing deterministic metrics while using AI only for executive note drafting

The author emphasizes that the differentiation is not in adding more OR metrics, but in governance layering—joining dependency visibility, action ownership, disruption attribution, longitudinal workflow performance, and operational-financial interpretation.

Inferred:

• The product is positioned as a decision-support tool, not clinical guidance.
• AI is used narrowly to draft executive language from controlled inputs, with human review required.

Not evidenced:

• Any commercial positioning or messaging beyond the prototype’s self-description
• Claims of market traction or customer feedback

The description states that Surgemetry targets perioperative leadership in hospitals. It is designed to help leaders understand surgical case performance by connecting data from multiple systems.

It is not described as targeting end-users like clinicians, nurses, or schedulers, but rather hospital administrators and operational decision-makers who need accountability and governance over surgical workflows.

Inferred:

• The product is likely aimed at hospital operations teams, finance departments, or perioperative managers.

Not evidenced:

• Specific customer personas or use cases beyond the prototype’s scope
• Any existing customers or pilot programs
• Whether the target audience includes multiple hospital types or sizes

The description does not provide any evidence of a business model or pricing structure.

It states that Surgemetry is not production-ready, and that it has no live hospital connectors, no PHI handling, and no claim of HIPAA compliance. It also notes that the prototype uses synthetic data and local files.

Inferred:

• The product is likely in early-stage development, with no revenue or pricing model yet defined.

Not evidenced:

• Any commercialization strategy
• Revenue streams or pricing plans
• Customer acquisition or monetization approach

The prototype was built using:

• Python, pandas, NumPy, Streamlit, Altair, Pydantic, pytest
• Synthetic datasets and deterministic calculations
• Optional GPT-5.6 integration for executive note drafting
• Local CSV files, SHA-256 hash chains, Markdown reporting

It includes:

• Nine Streamlit tabs with case-level drill-downs
• Regenerable reporting
• A local tamper-evident audit demonstration
• Automated tests and copyright-safe evidence controls

Not evidenced:

• Any live system integrations or APIs
• Security architecture or compliance features
• Scalability or performance metrics
• Production-ready infrastructure or deployment methods

The description states that Surgemetry is a synthetic prototype built for the OpenAI 2026 hackathon. It includes:

• A vertical slice across seven synthetic datasets
• Case-level drill-downs in nine Streamlit tabs
• Deterministic calculations and optional GPT integration

It explicitly states that it has no live hospital connectors, no PHI, no validated clinical or financial conclusions, and no production security controls.

Inferred:

• The project is early-stage, with no real-world traction or adoption.

Not evidenced:

• Any customer feedback or usage data
• Any revenue or ARR
• Any pilot programs or partnerships
• Evidence of product-market fit

The description does not mention any direct competitors.

It notes that systems like Epic, Oracle Health/Cerner, AdaptX, and others are prospective integration paths, but they are not implemented in the prototype. It also mentions HL7v2, FHIR, SMART, SFTP, and vendor APIs as potential future integrations.

Inferred:

• The product may compete with or complement existing hospital information systems (HIS) and perioperative management tools.

Not evidenced:

• Any competitive analysis or market positioning against existing solutions
• Market size or competitive landscape data
• Evidence of prior competitors or substitutes in the space

• No production readiness: The prototype is not HIPAA-compliant, has no live connectors, and handles no PHI.
• Early-stage prototype: Built for a hackathon, with no evidence of real-world testing or adoption.
• AI integration is limited: GPT-5.6 is used only for drafting executive notes, not for decision-making or data processing.
• No commercial model: No pricing, revenue, or customer data are provided.
• Unproven market demand: No evidence of traction, customers, or validated use cases beyond the prototype.

Not evidenced:

• Any risk mitigation strategies or plans to scale the product
• Evidence of founder experience in healthcare or SaaS

1. What specific perioperative workflows are you targeting, and how do you plan to validate those use cases?
2. How do you intend to integrate with existing hospital systems like Epic or Cerner?
3. What is your path to HIPAA compliance and production readiness?
4. Have you spoken with any hospitals or healthcare decision-makers about the value proposition?
5. What are the key assumptions in your model, and how will you test them?
6. How do you plan to monetize this product once it moves beyond prototype stage?
7. What is the timeline for moving from prototype to production-ready solution?